Loading clinical trials...
Loading clinical trials...
A Phase 2a Randomized, Placebo-Controlled, Double-Blind, Multi-Center Dose Escalation Study, to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011, in Subjects With Moderately Active Ulcerative Colitis
Conditions
Interventions
AG011
Placebo
Locations
18
Belgium
Imelda Bonheiden
Bonheiden, Belgium
UCL St. Luc
Brussels, Belgium
UZ Antwerpen
Edegem, Belgium
UZ Gent
Ghent, Belgium
AZ Groeninge Campus St.-Niklaas
Kortrijk, Belgium
UZ Leuven
Leuven, Belgium
Start Date
July 1, 2008
Primary Completion Date
September 1, 2009
Completion Date
September 1, 2009
Last Updated
September 10, 2009
Lead Sponsor
ActoGeniX N.V.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions